Allogene Therapeutics Inc (ALLO)
2.91
+0.15
(+5.43%)
USD |
NASDAQ |
May 01, 16:00
2.91
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Cash from Operations (Quarterly): -53.71M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -53.71M |
| September 30, 2023 | -55.53M |
| June 30, 2023 | -61.86M |
| March 31, 2023 | -66.64M |
| December 31, 2022 | -62.10M |
| September 30, 2022 | -47.66M |
| June 30, 2022 | -42.53M |
| March 31, 2022 | -68.24M |
| December 31, 2021 | -45.44M |
| September 30, 2021 | -48.88M |
| June 30, 2021 | -41.17M |
| March 31, 2021 | -49.33M |
| Date | Value |
|---|---|
| December 31, 2020 | -9.975M |
| September 30, 2020 | -37.59M |
| June 30, 2020 | -26.72M |
| March 31, 2020 | -40.81M |
| December 31, 2019 | -50.27M |
| September 30, 2019 | -31.94M |
| June 30, 2019 | -24.89M |
| March 31, 2019 | -30.26M |
| December 31, 2018 | -21.48M |
| September 30, 2018 | -17.13M |
| June 30, 2018 | -6.047M |
| March 31, 2018 | 0.005M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-68.24M
Minimum
Mar 2022
-9.975M
Maximum
Dec 2020
-45.54M
Average
-47.66M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| Agenus Inc | -40.40M |
| ANI Pharmaceuticals Inc | 44.74M |
| Vaxart Inc | -13.52M |
| aTyr Pharma Inc | -11.06M |
| PAVmed Inc | -11.87M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 67.46M |
| Cash from Financing (Quarterly) | 0.155M |
| Free Cash Flow | -239.25M |
| Free Cash Flow Per Share (Quarterly) | -0.3199 |
| Free Cash Flow to Equity (Quarterly) | -53.89M |
| Free Cash Flow Yield | -52.41% |